Cytec Industries, Inc. (CYT) Tops Q3 EPS by 28c, Cuts FY11 Guidance
Tweet
Share
E-mailGet Alerts CYT Hot Sheet
Price: $3.02 --0%
Financial Fact:
Continuing operations: 0.83
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Continuing operations: 0.83
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Cytec Industries, Inc. (NYSE: CYT) reported Q3 adjusted EPS of $1.10, $0.28 better than the analyst estimate of $0.82. Revenue for the quarter came in at $778 million versus the consensus estimate of $762.86 million.
Cytec Industries, Inc. sees FY2011 EPS of $3.20-$3.40, versus prior guidance of $3.25-$3.50 and the consensus of $3.27. Cytec Industries, Inc. sees FY2011 revenue of $3-$3.1 million, versus prior guidance of $3.0-$3.2 million and the consensus of $3.07 million.
Cytec Industries, Inc. sees FY2011 EPS of $3.20-$3.40, versus prior guidance of $3.25-$3.50 and the consensus of $3.27. Cytec Industries, Inc. sees FY2011 revenue of $3-$3.1 million, versus prior guidance of $3.0-$3.2 million and the consensus of $3.07 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
